{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:01:44Z","timestamp":1791273704973,"version":"4.1.0"},"reference-count":17,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,12]]},"abstract":"<jats:p>SF3B1 mutations were recently reported in myelodysplastic syndromes (MDSs), especially in the presence of ring sideroblasts (RSs). We sought to define the interaction between SF3B1 mutations, morphology, karyotype, and prognosis in MDS with more than or equal to 15% RS (MDS-RS). We studied 107 patients with MDS-RS, including 48 with refractory anemia with RS (RARS), 43 with refractory cytopenia with multilineage dysplasia (RCMD)-RS, 11 with refractory anemia with excess blasts-1 (RAEB1)\u2013RS, and 5 with RAEB2-RS. SF3B1 mutations were detected in 53 (\u223c 50%) patients: 35 RARS (73%), 16 RCMD-RS (37%), and 2 RAEB1-RS (18%). In univariate analysis, the presence of SF3B1 mutations was associated with better overall (P &lt; .01) and leukemia-free (P &lt; .01) survival; however, in both instances, significance was completely accounted for by World Health Organization morphologic risk categorization. In other words, when RARS and RCMD-RS were analyzed separately, there was no additional prognostic value from the presence or absence of SF3B1 mutations.<\/jats:p>","DOI":"10.1182\/blood-2011-09-377994","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T20:20:35Z","timestamp":1321561235000},"page":"569-572","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":182,"title":["SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value"],"prefix":"10.1182","volume":"119","author":[{"given":"Mrinal M.","family":"Patnaik","sequence":"first","affiliation":[{"name":"Divisions of Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[{"name":"Divisions of Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Hodnefield","sequence":"additional","affiliation":[{"name":"Hematopathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[{"name":"Cytogenetics, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[{"name":"Cytogenetics, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[{"name":"M. D. Anderson Cancer Center, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Steensma","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Pardanani","sequence":"additional","affiliation":[{"name":"Divisions of Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Hematopathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[{"name":"Divisions of Hematology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111814014000000_B1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of Myelodysplastic Syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"2019111814014000000_B2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3324\/haematol.2011.044628","article-title":"Ring sideroblasts and sideroblastic anemias.","volume":"96","author":"Cazzola","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"2019111814014000000_B3","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.89.9.4028","article-title":"Enzymatic defect in \u201cX-linked\u201d sideroblastic anemia:molecular evidence for erythroid delta-aminolevulinate synthase deficiency.","volume":"89","author":"Cotter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111814014000000_B4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","article-title":"Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.","volume":"41","author":"Guernsey","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"2019111814014000000_B5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tig.2008.05.008","article-title":"Iron-sulfur cluster biogenesis and human disease.","volume":"24","author":"Rouault","year":"2008","journal-title":"Trends Genet"},{"issue":"5","key":"2019111814014000000_B6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/hmg\/8.5.743","article-title":"Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA\/A).","volume":"8","author":"Allikmets","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2019111814014000000_B7","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","article-title":"The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.","volume":"3","author":"Boultwood","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"2019111814014000000_B8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"issue":"15","key":"2019111814014000000_B9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"key":"2019111814014000000_B10","article-title":"SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. [published online ahead of print, September 2, 2011].","author":"Visconte","journal-title":"Leukemia"},{"issue":"7367","key":"2019111814014000000_B11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia.","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"5621","key":"2019111814014000000_B12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1084155","article-title":"Molecular architecture of the multiprotein splicing factor SF3b.","volume":"300","author":"Golas","year":"2003","journal-title":"Science"},{"key":"2019111814014000000_B13","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0145-2126(11)70016-9","article-title":"Revised International Prognostic Scoring System (IPSS-R) developed by the International Working Group for Prognosis in MDS (IWG-PM).","volume":"35","author":"Greenberg","year":"2011","journal-title":"Leuk Res"},{"issue":"10","key":"2019111814014000000_B14","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111814014000000_B15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/leu.2010.113","article-title":"IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"2019111814014000000_B16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.leu.2405097","article-title":"Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival.","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"2019111814014000000_B17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation.","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/2\/569\/1496618\/zh800212000569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/2\/569\/1496618\/zh800212000569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:01:49Z","timestamp":1574085709000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/2\/569\/105456\/SF3B1-mutations-are-prevalent-in-myelodysplastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-09-377994","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}